VITAL PHARMA AS

7052 TRONDHEIM

Finances

Share Ownership

Return on Equity

−93,78 %

Current Ratio

1,2

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	8 746 000	4 650 000	8 753 000	10 538 000
Net Income	−181 000	322 000	584 000	59 000
Total Assets	1 139 000	1 239 000	838 000	807 000
Total Equity	193 000	374 000	52 000	−532 000

Income (NOK)	2022	2021	2020	2019
Revenue	8 746 000	4 650 000	8 753 000	10 538 000
Expenditure	8 901 000	4 310 000	8 152 000	10 462 000
Operating Profit	−154 000	340 000	601 000	75 000
Financial Income	0	1 000	0	1 000
Financial Costs	27 000	20 000	17 000	17 000
Financial Balance	−27 000	−19 000	−17 000	−16 000
Earnings Before Tax	−181 000	322 000	584 000	59 000
Tax	0	0	0	0
Net Income	−181 000	322 000	584 000	59 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	1 139 000	1 239 000	838 000	807 000
Total Assets	1 139 000	1 239 000	838 000	807 000
Total Retained Equity	88 000	269 000	−53 000	−637 000
Total Equity	193 000	374 000	52 000	−532 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	947 000	865 000	786 000	1 340 000
Total Equity and Debt	1 139 000	1 239 000	838 000	807 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	8 746 000	4 650 000	8 753 000	10 538 000
Other Income	0	0	0	0
Revenue	8 746 000	4 650 000	8 753 000	10 538 000
Cost of Goods Sold	4 476 000	1 936 000	3 828 000	2 453 000
Salary Costs	3 845 000	1 540 000	1 251 000	4 357 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	8 901 000	4 310 000	8 152 000	10 462 000
Operating Profit	−154 000	340 000	601 000	75 000
Financial Income	0	1 000	0	1 000
Financial Costs	27 000	20 000	17 000	17 000
Financial Balance	−27 000	−19 000	−17 000	−16 000
Dividends	0	0	0	0
Net Income	−181 000	322 000	584 000	59 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	435 000	470 000	493 000	348 000
Total Investments	0	0	0	0
Cash, Bank	631 000	720 000	312 000	57 000
Total Current Assets	1 139 000	1 239 000	838 000	807 000
Total Assets	1 139 000	1 239 000	838 000	807 000
Total Equity	193 000	374 000	52 000	−532 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	86 000	556 000	599 000	262 000
Unpaid Taxes	495 000	178 000	94 000	477 000
Dividends	0	0	0	0
Other Current Debt	366 000	131 000	93 000	397 000
Total Current Debt	947 000	865 000	786 000	1 340 000
Total Equity and Debt	1 139 000	1 239 000	838 000	807 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−93,78 %	86,1 %	1 123,08 %	−11,09 %
Debt-to-Equity Ratio	0	0	0	−0
Operating Profit Margin	−1,76 %	7,31 %	6,87 %	0,71 %
Current Ratio	1,2	1,43	1,07	0,6
Quick Ratio	2,22	3,14	2,86	0,81
Equity Ratio	0,17	0,3	0,06	−0,66
Gross Profit Margin	48,82 %	58,37 %	56,27 %	76,72 %